believe study of bimagrumab + semaglutide and combo shows promising results in weight loss and body composition | Zain Khalpey, MD, PhD, FACS posted on the topic I think by now, we

Most participants in the STEP trials reported that gastrointestinal symptoms resolved or became minimal within 4 to 8 weeks of maintaining a stable dose

To support muscle, overall health, and prevent potential deficiencies while using GLP-1 medications, I recommend: Anchor meals and snacks with protein

GLP-1 activators address the biological root of overeating by resetting how your brain perceives hunger and satiety, making dietary adherence feel less like willpower and more like natural preference

2022 Aug;24(8):155364

GLP-1 receptor agonists gained significant increases in prescriber popularity in 2021, with Semaglutide accounting for 60% of prescriptions by 2023 due to its superior efficacy in clinical trials compared to Liraglutide (22)